Abstract
Background
Richardson’s syndrome (RS) is considered the most symmetric phenotype of progressive supranuclear palsy (PSP) as opposed to PSP with predominant corticobasal syndrome (PSP-CBS) or parkinsonism (PSP-P).
Objectives
Evaluate asymmetrical motor and higher cortical features in probable PSP-RS and compare the degree of asymmetry of cortical lobes and hemispheres between PSP-RS, PSP-CBS, PSP-P, and age-matched healthy controls (HC).
Methods
Asymmetry of motor and higher cortical features evaluated with an extensive videotaped neurologic examination was investigated in 28 PSP-RS, 8 PSP-CBS, and 14 PSP-P. Brain MRI to compute the laterality index (LI) was performed in 36 patients as well as in 56 HC.
Results
In PSP-RS, parkinsonism was the most common asymmetric motor feature (53.6%), followed by dystonia and myoclonus (21.4% and 17.9%, respectively). Among higher cortical features, limb apraxia was found asymmetric in about one-third of patients. PSP-RS disclosed higher LI for hemispheres compared to HC, indicating a greater degree of asymmetry (p = 0.003). The degree of asymmetry of clinical features was not different between PSP-RS and those qualifying for PSP-CBS or PSP-P. As for imaging, LI was not different between PSP-RS, PSP-CBS, and PSP-P in any cortical region.
Conclusions
Motor and higher cortical features are asymmetric in up to 50% of PSP-RS who also present a greater degree of asymmetry in hemispheres compared to age-matched HC. Lateralization of clinical features should be annotated in PSP.
Similar content being viewed by others
Introduction
RS is the most common phenotype of PSP and is characterized by the early onset of postural instability and falls and vertical supranuclear gaze palsy [1]. Traditionally, and as opposed to other phenotypes of disease, PSP-RS has been considered a symmetric disease [2,3,4]. Indeed, prominent asymmetric clinical features prompt clinicians to consider either PSP-CBS or PSP-P [1]. On a clinical ground and given the lack of biomarkers, the correct identification of the latter phenotypes often represents a clinical challenge and, despite the rigorous application of clinical diagnostic criteria, the final diagnosis is often based on clinical judgment [1, 5].
Although current clinical diagnostic criteria for probable PSP show high sensitivity and specificity, definite PSP remains a neuropathological diagnosis as in vivo biomarkers are lacking [1]. Despite the adequate diagnostic accuracy of the operational algorithm suggested, the different phenotypes of the disease show massive overlap and, thus, clinical classification often represents a difficult work [1, 5, 6]. Furthermore, patients classified as PSP-RS can show asymmetric clinical features or have a neuropathologic diagnosis of corticobasal degeneration [7, 8]. Likewise, patients showing asymmetrical clinical features can present neuropathology typical for PSP [9].
As the PSP rating scale, the most frequently used tool to rate disease severity in PSP, does not value lateralization, detailed information on the asymmetry of clinical features in PSP-RS is lacking [10]. Similarly, no evidence is available on the degree of asymmetry of cortical regions in PSP-RS compared to PSP-CBS and PSP-P or healthy controls (HC).
Objectives of the present retrospective chart review were to (1) systematically evaluate asymmetrical motor and higher cortical features in a cohort of probable PSP-RS diagnosed according to current clinical criteria in comparison with the other variant syndromes of PSP (i.e., PSP-CBS and PSP-P); (2) compare the degree of asymmetry of cortical lobes and hemispheres between PSP-RS and age-matched PSP-CBS and PSP-P and HC; (3) explore correlations between clinical and radiological asymmetry.
Methods
Patients and clinical evaluation
Twenty-eight patients with probable PSP-RS, 8 with possible PSP-CBS, and 14 with probable PSP-P according to the Movement Disorder Society (MDS) criteria were included in the present analysis [1]. Detailed information on enrollment and application of the PSP diagnostic criteria is available elsewhere [6, 11,12,13]. All assessments were videotaped. Briefly, 83 PSP outpatients were enrolled from the Movement Disorders Centers of the University of Salerno between November 2015 and December 2019. Thirty-three patients were excluded because they either had incomplete data (N = 7) or qualified for other phenotypes other than probable or possible PSP-RS and PSP-P or possible PSP-CBS by applying MDS guidelines (N = 26) [1, 5]. Excluded patients had a median (interquartile age) of 68 (8) years. Eighteen (54.5%) were men, and the median disease duration was 2 (3) years.
Motor features, including bradykinesia, rigidity, rest tremor, and dystonia were evaluated with specific items from the Neuroprotection and Natural History in Parkinson Plus Syndromes (NNIPPS) scale [14]. Any features presenting a different scoring between the right and left side were deemed as asymmetric: bradykinesia, rigidity, tremor, and dystonia (corresponding NNIPPS items are detailed in Table 1). As NNIPPS provides no information on lateralization for myoclonus, such a feature was excluded from the present analysis.
As for higher cortical features, limb apraxia was explored with the ideomotor apraxia test for each side [6, 15]. The test consists of 24 tasks, 12 concern symbolic gestures, and 12 nonsymbolic gestures; each task is performed for a maximum of three times, and the maximum score is 72. In accordance with the Italian correction criteria, raw scores less than 53 were considered pathological; scores between 53 and 62 were considered borderline, i.e., representative of a probable but uncertain diagnosis, and all scores above 62 were considered within the normal range [6, 15]. Any different ranking between right and left was deemed as asymmetric. Alien limb phenomenon was not included in the evaluation, as no objective score was administered. Of note, none of the patients presented bilateral alien limb phenomena.
Furthermore, for each clinical feature, the degree of asymmetry was calculated with the percentage ratio between the absolute value of the difference between left and right score and the sum of them, as follows: LI = ((left − right)/(left + right)) × 100, where lower LI values indicate a decrease of the degree of asymmetry for the specific feature, i.e., LI = 0 when left = right. Thus, in this work, the LI represents an asymmetry measure not directed toward one particular side of the body. Right or left predominance was attributed by reviewing the scores within each item (i.e., a greater scoring on the right was interpreted as right predominance).
MRI imaging protocol
Brain MRI was performed in all PSP-CBS, a subset of 17 PSP-RS and 11 PSP-P patients and in 56 age-matched HC (median age (interquartile range) 69 (10)] on a 3 T system (Magnetom Skyra, Siemens, Erlangen, Germany). A volumetric 3D T1-weighted magnetization prepared rapid gradient echo (MPRAGE) sequence was acquired with the following parameters: repetition time = 2400 ms, echo time = 2.25 ms, resolution = 1 × 1 × 1 mm3, matrix size = 256 × 256, 192 sagittal slices, anterior–posterior phase-encoding direction, generalized autocalibrating partially parallel acquisition (GRAPPA) factor of 2 in phase-encoding direction. MPRAGE images were processed using FreeSurfer version 6.0 (https://surfer.nmr.mgh.harvard.edu/) using the standard structural image preprocessing and surface reconstruction pipeline via the “recon-all" command (for a detailed description of this procedure, please see https://surfer.nmr.mgh.harvard.edu/fswiki/ReconAllTableStableV5.3) [16]. Preprocessed data were visually inspected to assure the quality of each reconstruction. Cortical volume was extracted for each region of the Desikan–Killiany cortical atlas, and then regions were merged (and volumes were summed) to obtain one regional value for each cerebral lobe (frontal, parietal, occipital, temporal, and cingulate) as well as for each hemisphere [16, 17]. The total intracranial volume was also considered and compared between groups.
The degree of asymmetry for each cerebral lobe as well as hemispheres was calculated with the percentage ratio between the absolute value of the difference between left and right raw volume (not normalized by intracranial volume) and the sum of them, as follows: LI = ((left − right)/(left + right)) × 100, where lower LI values indicate a decrease of the degree of asymmetry in the specific structure, i.e., LI = 0 when left = right. Thus, in this work, the LI represents an asymmetry measure not directed toward one particular hemisphere.
Standard protocol approvals, registrations, and patient consent
The project was approved by the local ethics committee, and each subject was included after signing the informed consent form.
Statistical analysis
After checking normality distribution with the Kolmogorov–Smirnov test, group comparisons were run with χ2, Mann–Whitney, or Kruskal–Wallis test as appropriate. Correlation analysis was performed with the Spearman’s test. All p-values were 2-tailed, and the significance threshold was set at ≤ 0.05. Post hoc analysis was run with the Bonferroni test. The statistical analysis was conducted using SPSS 23.0 (IBM, Chicago, IL, USA).
Results
Asymmetric motor and higher cortical features in PSP-RS
Enrolled patients had a median (interquartile range) age of 71 (10) years. Thirteen (46.4%) were men, and the median disease duration was 3 (3) years. More than 95% complained of falls at the onset of disease. The frequency of asymmetry with side predominance for each asymmetric motor and higher cortical feature is detailed in Table 1.
As for motor symptoms, bradykinesia and rigidity were asymmetric in more than 50% of the cohort, while the rest tremor only in 14.3%. Parkinsonism was the most common asymmetric motor feature (53.6%), followed by dystonia and myoclonus (21.4% and 17.9% each).
As for higher cortical features, limb apraxia was found asymmetric in about one-third of patients (35.7%), while alien limb was not present in any patient.
Comparison between PSP-RS, PSP-CBS, and PSP-P
Demographic and clinical features in PSP-RS compared to PSP-CBS and PSP-P are detailed in Table 2. LI for each clinical feature was not different between groups (p > 0.05) (Fig. 1).
Degree of asymmetry of cortical lobes and hemispheres: comparison between PSP-RS, PSP-CBS, PSP-P, and HC
The volume of cerebral lobes was not normalized by intracranial volume, as this was not different between groups (p = 0.706).
Kruskal–Wallis showed LI for hemispheres was different between groups (p = 0.006) with PSP-RS presenting a greater degree of asymmetry compared to HC (p = 0.003) (Fig. 2). No other difference in LI was detected for other lobes (all p > 0.05).
Correlation between clinical and radiological asymmetry
Spearman’s test did not disclose any significant correlation between clinical and radiological LI (p > 0.05).
Discussion
This is the first systematic assessment of asymmetry in motor and higher cortical features in PSP-RS. Contradicting previous evidence [2,3,4], we showed that parkinsonism, dystonia, and myoclonus are asymmetric in a relevant proportion of PSP-RS (53.6%, 21.4%, and 17.9% each). In a lower proportion of patients, asymmetry was revealed also for higher cortical features such as limb apraxia (35.7%).
A large body of literature refers to PSP-RS as a symmetric disease [2,3,4]. As a result, the most widely used instrument to assess disease severity and progression in the context of clinical trials, the PSP rating scale, lacks a scoring system reporting asymmetry of clinical features [10]. Similarly, the PSP Clinical Deficits Scale recently released by the MDS does not provide any information on lateralization in the akinesia-rigidity and finger dexterity functional domains [18]. Notwithstanding, in line with previous reports also including pathologically proven cases, our data show that asymmetry can be present in PSP-RS [7,8,9].
Asymmetric clinical features in our cohort of PSP-RS were detected with the application of a rigorous protocol, including videotaped NNIPPS and neurological examination as well as the ideomotor apraxia test. Of note, the consistency of our results is supported by several findings. First, the different tasks evaluating bradykinesia presented a similar rate of asymmetry (Table 1, Fig. 1). Second, bradykinesia and rigidity, the two most relevant parkinsonian features, also showed similar rates of asymmetry. Asymmetry rates were higher in the upper compared to lower limbs. An assessment bias with a greater number of items evaluating the upper limbs may account for such discrepancy. Alternatively, we can not exclude a greater rate of asymmetry in the upper, compared to lower limbs.
The relevance of clinical asymmetry was further supported by the evidence of a significant degree of morphological cortical hemispheric asymmetry in PSP-RS compared to age-matched HC but not compared to the other variant syndromes of PSP (Fig. 2).
Comparing clinical features of PSP-RS with patients qualifying for the other variant syndromes of PSP disclosed similar rates of asymmetry (Fig. 2). In agreement with clinical findings, the laterality index did not differ between PSP-RS and those qualifying for PSP-CBS or PSP-P in any cortical region. Taken together, our findings suggest asymmetry should not be mentioned among major features differentiating PSP-RS from PSP-CBS and PSP-P.
Our data have practical implications. The distribution of clinical features should not be considered in support of the phenotypic characterization of PSP patients (i.e., symmetric in PSP-RS versus asymmetric in PSP-CBS and PSP-P). Furthermore, clinical evaluation of PSP patients should also include ratings of motor and cortical features for each side of the body. Given the lack of reliable radiological markers [12], our study further confirms the difficulty in differentiating PSP clinical phenotypes as theorized by the MDS [6, 10].
Our study has limitations. First, we recognize the lack of pathological confirmation of both diagnosis and phenotypic categorization, which remains the gold standard for PSP diagnosis. However, the MDS diagnostic flow chart and phenotypic attribution have been applied rigorously by experts in movement disorders, all patients underwent detailed clinical examination and imaging ruled out vascular lesions as well as signs suggesting the presence of normal pressure hydrocephalus [12]. We also acknowledge some patients may have evolved into PSP-RS after having started out as PSP-P or PSP-CBS. However, we enrolled a population of early PSP-RS patients (median disease duration = 3 years), and more than 95% complained of falls at onset of disease, further corroborating PSP-RS was the starting phenotype. As a second limitation, we acknowledge our cohort only included a cross-sectional evaluation. However, all patients but those qualifying for PSP-CBS already reached a degree of diagnostic certainty of probability. Also, we did not evaluate the dopamine transporter SPECT imaging asymmetry index as enrolled patients did not perform such exams systematically at our center. Furthermore, our results should be interpreted with caution due to the small sample size of PSP phenotypes. Finally, we also recognize the lack of evaluation of cortical sensory loss among the higher cortical features. We performed the regional analysis using the Desikan–Killiany cortical atlas (and then the lobe parcellation), the standard parcellation included in the Freesurfer framework as it is the most used in morphological analysis and it is adapted to every subject’s anatomy. Nevertheless, we recognize we may have missed subtle asymmetries or small alterations considering the big sizes of the regions.
In conclusion, the present study demonstrates that motor and higher cortical features are asymmetric in a relevant proportion of PSP-RS (up to 50%). PSP-RS patients also present a greater degree of asymmetry in hemispheres compared to age-matched HC but not compared to the other variant syndromes of PSP. The distribution of clinical features should be considered in the clinical characterization of PSP patients.
Availability of data and material
The dataset of the present study is available from the corresponding author upon request.
Abbreviations
- HC:
-
Healthy controls
- LI:
-
Laterality index
- MDS:
-
Movement Disorder Society
- MRI:
-
Magnetic resonance imaging
- PSP:
-
Progressive supranuclear palsy
- NNIPPS:
-
Neuroprotection and Natural History in Parkinson Plus Syndromes
- PSP-CBS:
-
Progressive supranuclear palsy with predominant corticobasal syndrome
- PSP-P:
-
Progressive supranuclear palsy with predominant parkinsonism
- RS:
-
Richardson’s syndrome
References
Hoglinger GU, Respondek G, Stamelou M, et al; Movement Disorder Society-endorsed PSP Study Group (2017) Clinical diagnosis of progressive supranuclear palsy: the movement disorder society criteria. Mov Disord 32:853–864.
Litvan I, Agid Y, Calne D et al (1996) Clinical reserach criteria for the diagnosis of progressive supranuclear palsy: report of the NINDS-SPSP international workshop. Neurology 47(1):1–9
Litvan I, Mangone CA, McKee A et al (1996) Natural history of progressive supranuclear palsy (Steele-Richardson-Olszewski syndrome) and clinical predictors of survival: a clinicopathological study. J Neurol Neurosurg Psychiatry 60(6):615–620
Respondek G, Hoglinger GU. (2016) The phenotypic spectrum of progressive supranuclear palsy. 22Suppl1:S34–36.
Grimm MJ, Respondek G, Stamelou M, et al; Movement Disorder Society-endorsed PSP Study Group. (2019) How to apply the movement disorder society criteria for diagnosis of progressive supranuclear palsy. Mov Disord 34:1228–1232.
Picillo M, Cuoco S, Tepedino MF,: Salerno PSP study group, et al (2019) Motor, cognitive and behavioral differences in MDS PSP phenotypes. J Neurol 266:1727–1735
Stezin A, Holla VV, Chaithra SP et al (2019) Asymmetric limb dystonia in progressive supranuclear palsy: conundrum in nosology. Movement Disorders Clinical Practice 6:415–416
Bayram E, Dickson D, Reich S, Litvan I (2020) Pathology-proven corticobasal degeneration presenting as Richardson’s syndrome. Mov Disord Clin Pract 7:267–272
Oide T, Ohara S, Yazawa M et al (2002) Progressive supranuclear palsy with asymmetric tau pathology presenting with unilateral limb dystonia. Acta Neuropathol 104:209–214
Golbe LI, Ohman-Strickland PA (2007) A clinical rating scale for progressive supranuclear palsy. Brain 130:1552–1565
Picillo M, Erro R, Cuoco S,: PSP Salerno study group, et al (2018) MDS PSP criteria in real-life clinical setting: motor and cognitive characterization of subtypes. Mov Disord 33:1361–1365
Picillo M, Tepedino MF, Abate F et al (2020) Midbrain MRI assessments in progressive supranuclear palsy subtypes. J Neurol Neurosurg Psychiatry 91:98–103
Picillo M, Abate F, Ponticorvo S, et al (2020) Association of MRI measures with disease severity and progression in progressive supranuclear palsy. Front Neurol 11:603161.
Payan CA, Viallet F, Landwehrmeyer BG et al (2011) NNIPPS Study Group. Disease severity and progression in progressive supranuclear palsy and multiple system atrophy: validation of the NNIPPS–Parkinson Plus Scale. PLoS One 6(8):e22293.
De Renzi E, Motti F, Nichelli P. (1980) Imitating gestures. A quantitative approach to ideomotor apraxia. Arch Neurol 37(1):6–10.
Dale AM, Sereno MI (1993) Improved localization of cortical activity by combining EEG and MEG with MRI cortical surface reconstruction: a linear approach. J Cogn Neurosci 5(2):162–176
Desikan RS, Ségonne F, Fischl B et al (2006) An automated labeling system for subdividing the human cerebral cortex on MRI scans into gyral based regions of interest. Neuroimage 31(31):968–980
Piot I, Schweyer L, Respondek G et al (2020) The Progressive Supranuclear Palsy Clinical Deficits Scale. Mov Disord 35:650–651
Funding
The present work has been funded by the University of Salerno (FARB2018). Dr. Marina Picillo is supported by the Michael J Fox Foundation for Parkinson’s research; Prof Paolo Barone received consultancies as a member of the advisory board for Zambon, Lundbeck, UCB, Chiesi, Abbvie, and Acorda; Dr. Roberto Erro received consultancies from Zambon and honoraria from TEVA; the other authors report no financial disclosures.
Author information
Authors and Affiliations
Contributions
Research project: conception, MP; organization, MP, RM, and PB; execution, MFP, FA, SP, RE, SC, NO, GDS, FDS, FE, and MTP; statistical analysis: design, MP; execution, MP; review and critique, MFP, FA, SP, RE, SC, NO, GDS, FDS, FE, MTP, RM, and PB; manuscript preparation: writing of the first draft, MP; review and critique, MFP, FA, SP, RE, SC, NO, GDS, FDS, FE, MTP, RM, and PB.
Corresponding author
Ethics declarations
Ethical approval
The present study has been approved by the Ethics Committee Campania sud. All patients provided written informed consent upon inclusion in the study. We confirm that we have read the Journal’s position on issues involved in ethical publication and affirm that this work is consistent with those guidelines.
Conflict of interest
The authors declare no competing interests.
Additional information
Publisher’s note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.
About this article
Cite this article
Picillo, M., Tepedino, M.F., Abate, F. et al. Uncovering clinical and radiological asymmetry in progressive supranuclear palsy—Richardson’s syndrome. Neurol Sci 43, 3677–3682 (2022). https://doi.org/10.1007/s10072-022-05919-x
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10072-022-05919-x